![3 month randomised double blind, placebo-controlled phase followed by a 24-month open-label, single-arm phase. The primary endpoint of the trial was to compare the efficiency (4) - The Butterfly Skin Charity 3 month randomised double blind, placebo-controlled phase followed by a 24-month open-label, single-arm phase. The primary endpoint of the trial was to compare the efficiency (4) - The Butterfly Skin Charity](https://debraireland.org/wp-content/uploads/3-month-randomised-double-blind-placebo-controlled-phase-followed-by-a-24-month-open-label-single-arm-phase.-The-primary-endpoint-of-the-trial-was-to-compare-the-efficiency-4.png)
3 month randomised double blind, placebo-controlled phase followed by a 24-month open-label, single-arm phase. The primary endpoint of the trial was to compare the efficiency (4) - The Butterfly Skin Charity
![A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0261561419300822-fx1.jpg)
A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect
Randomized, double-blind, placebo-controlled clinical trial flow. The... | Download Scientific Diagram
![Study flow chart. In this randomised, double-blind, placebo-controlled... | Download Scientific Diagram Study flow chart. In this randomised, double-blind, placebo-controlled... | Download Scientific Diagram](https://www.researchgate.net/publication/228323301/figure/fig3/AS:271243286937613@1441680847536/Study-flow-chart-In-this-randomised-double-blind-placebo-controlled-study.png)
Study flow chart. In this randomised, double-blind, placebo-controlled... | Download Scientific Diagram
![Randomized, Double-Blind, Placebo-Controlled Trial of Orlistat for Weight Loss in Adolescents - Endocrine Practice Randomized, Double-Blind, Placebo-Controlled Trial of Orlistat for Weight Loss in Adolescents - Endocrine Practice](https://www.endocrinepractice.org/cms/asset/f9b016fe-bd8d-4a93-a587-d4f33837b0e9/gr1.jpg)
Randomized, Double-Blind, Placebo-Controlled Trial of Orlistat for Weight Loss in Adolescents - Endocrine Practice
![A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS | Future Cardiology A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS | Future Cardiology](https://www.futuremedicine.com/cms/10.2217/fca-2016-0026/asset/images/medium/figure1.gif)
A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS | Future Cardiology
![A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia: Molecular Therapy A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia: Molecular Therapy](https://www.cell.com/cms/attachment/f7119006-e9eb-45cc-a48a-f2878fe07e4a/gr1.jpg)
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia: Molecular Therapy
![A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253820300260-fx1.jpg)
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect
Study design and flow chart of the double blind, placebo controlled and... | Download Scientific Diagram
![PAciFy Cough—a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary Fibrosis Cough | Trials | Full Text PAciFy Cough—a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary Fibrosis Cough | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-022-06068-4/MediaObjects/13063_2022_6068_Fig1_HTML.png)
PAciFy Cough—a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary Fibrosis Cough | Trials | Full Text
![Double-blind, placebo-controlled food challenges in Brazilian children: Adaptation to clinical practice | Allergologia et Immunopathologia Double-blind, placebo-controlled food challenges in Brazilian children: Adaptation to clinical practice | Allergologia et Immunopathologia](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S030105461200002X:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNe5umqYt0zKZP4SYniTZ7+SgZrkCgayp3MRA1ovxa2vU019/Ihelx+M06zJ5Nb90+iAeO0TXhnEW2Xc0K8pb8P5rBk6YF6Wq/01IWx7zb+O4xQS28z5rCDZiIm6VQYUaOR8PHuzxq5wLDjcpZCNuXHGvDyg6n6ok9Ks4ANqMdhVxB1scqL/agC5YxqDSFAl4drk6dxfzp93cAUh1om4gNkXuONA9ZQTOUoY5yYNOLb81YKZeuXvTy+00WsakM9s8FKzxlMRM3norgbwiFcbmL/g)
Double-blind, placebo-controlled food challenges in Brazilian children: Adaptation to clinical practice | Allergologia et Immunopathologia
![Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials - The Lancet Neurology Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials - The Lancet Neurology](https://www.thelancet.com/cms/attachment/d9b214ec-17e9-4b12-accc-fd7fc51849e2/gr1a.gif)
Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials - The Lancet Neurology
![Phase 1a Randomized Double-Blind Placebo-Controlled Single-Ascending Dose and Multiple-Ascending Dose Studies of Orally Inhaled GB002 in Healthy Adult Subjects - Gossamer Bio Phase 1a Randomized Double-Blind Placebo-Controlled Single-Ascending Dose and Multiple-Ascending Dose Studies of Orally Inhaled GB002 in Healthy Adult Subjects - Gossamer Bio](https://www.gossamerbio.com/wp-content/uploads/P903.png)
Phase 1a Randomized Double-Blind Placebo-Controlled Single-Ascending Dose and Multiple-Ascending Dose Studies of Orally Inhaled GB002 in Healthy Adult Subjects - Gossamer Bio
![A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia | American Society of Nephrology A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia | American Society of Nephrology](https://jasn.asnjournals.org/content/jnephrol/30/9/1723/F1.large.jpg)